Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis

2008-07-01

British Journal of Dermatology , Volume 159 - Issue 1 p. 257- 258

Additional Metadata
Keywords	Adalimumab, Methotrexate, Noninferiority, Placebo, Psoriasis, Randomized controlled trial
Persistent URL	doi.org/10.1111/j.1365-2133.2008.08606.x, hdl.handle.net/1765/29169
Journal	British Journal of Dermatology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Nijsten, T.E.C, & Spuls, P.I. (2008). Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis. British Journal of Dermatology, 159(1), 257–258. doi:10.1111/j.1365-2133.2008.08606.x

Publication